TirzepatideRx
Dual GIP/GLP-1 Receptor Agonist - Proven effective for medical weight loss at an affordable price
Join 95K+ happy patients • Rated ★★★★★ 4.8/5
What is Tirzepatide?
Tirzepatide is a dual GIP/GLP-1 receptor agonist for weight management. By activating two key hormone pathways instead of one, tirzepatide delivers superior weight loss results compared to semaglutide-based medications. Our compounded tirzepatide is prepared by 503B-certified US pharmacies that meet rigorous quality and safety standards.
Clinical trials show tirzepatide users lose an average of 20-22% of their body weight - nearly 50% more than patients taking semaglutide. This makes it the most effective weight loss medication currently available.
How Tirzepatide Works
Dual Hormone Action
Activates both GIP and GLP-1 receptors for enhanced appetite suppression and metabolic benefits.
Superior Weight Loss
Clinical trials show up to 22% weight loss - significantly more than single-action GLP-1 medications.
Improved Metabolism
Better blood sugar control and insulin sensitivity compared to semaglutide alone.
Benefits of Tirzepatide
Most Effective Treatment Available
Clinical trials show average 20-22% body weight loss - nearly double that of semaglutide
Dual-Action Mechanism
Works on both GIP and GLP-1 receptors for superior appetite control and metabolic benefits
Faster Results
Patients typically see weight loss results more quickly than with semaglutide alone
Once-Weekly Convenience
Simple weekly injection that fits seamlessly into your routine
Comprehensive Health Benefits
Improves blood sugar, cholesterol, blood pressure, and other metabolic markers
Clinically Proven Safety
Backed by extensive clinical research and rigorous testing
Tirzepatide vs Semaglutide
Compare the two leading GLP-1 medications
| Feature | Tirzepatide | Semaglutide |
|---|---|---|
| Weight Loss Results | 20-22% average | 10-15% average |
| Mechanism of Action | Dual GIP/GLP-1 | GLP-1 only |
| Monthly Cost | from $225 | from $155 |
| Source | US Compounding Pharmacy | US Compounding Pharmacy |
| Dosing Schedule | Once weekly | Once weekly |
Ready to Start Your Weight Loss Journey?
Get started with tirzepatide today. Complete a brief online consultation and get your prescription.
Get Started NowJoin 95K+ happy patients • Rated ★★★★★ 4.8/5
Frequently Asked Questions
Tirzepatide activates both GIP and GLP-1 receptors, while semaglutide only targets GLP-1. This dual action makes tirzepatide significantly more effective, with patients losing an average of 20-22% of body weight compared to 15% with semaglutide.
Many patients find the additional effectiveness worth the extra $70/month. Tirzepatide delivers nearly 50% more weight loss on average, helping you reach your goals faster and with better long-term results.
Side effects are similar to semaglutide - nausea, diarrhea, and constipation are most common. These are typically mild and improve as your body adjusts. We start with a low dose and gradually increase to minimize side effects.
Most patients notice appetite suppression within the first week. Visible weight loss typically starts within 4-6 weeks, with maximum effects after several months of treatment.
Yes, many patients upgrade to tirzepatide for enhanced results. Your care team will help you transition safely and adjust dosing appropriately.